Loading clinical trials...
Loading clinical trials...
The purpose of the study is to establish drug-induced liver injury databases in China, make criteria for Chinese drug-induced liver injury patients and evaluate the application of certain circulating ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beijing Ditan Hospital
NCT06872372 · Acute Liver Failure, Drug-Induced Liver Injury
NCT05517668 · Acetaminophen, Drug Overdose, and more
NCT03100786 · Tuberculosis, Tuberculous Meningitis, and more
NCT03211208 · Drug-Induced Liver Injury, Anti-Tuberculous Drug Reaction, and more
NCT06019936 · Drug-Induced Liver Injury, Cholestatic Liver Injury, and more
Beijing Ditan Hospital
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions